Allarity Therapeutics (ALLR) Short Interest Ratio & Short Volume → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free ALLR Stock Alerts $1.54 +0.04 (+2.67%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Allarity Therapeutics Short Interest DataCurrent Short Volume25,200 sharesPrevious Short Volume614,300 sharesChange Vs. Previous Month-95.90%Dollar Volume Sold Short$151,754.40Short Interest Ratio / Days to Cover0.8Last Record DateMarch 31, 2024Outstanding Shares310,000 sharesFloat Size274,600 sharesShort Percent of Float9.18%Today's Trading Volume864,937 sharesAverage Trading Volume401,157 sharesToday's Volume Vs. Average216% Short Selling Allarity Therapeutics ? Sign up to receive the latest short interest report for Allarity Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALLR Short Interest Over TimeALLR Days to Cover Over TimeALLR Percentage of Float Shorted Over Time Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story Allarity Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202425,200 shares $151,754.40 -95.9%9.2%0.8 $6.02 3/15/2024614,300 shares $213,162.10 -5.9%11.8%4.7 $0.35 2/29/2024652,700 shares $252,333.82 +1.9%12.5%1.5 $0.39 2/15/2024640,300 shares $260,281.95 +0.8%17.2%0.4 $0.41 1/31/2024635,000 shares $275,971.00 -6.0%N/A0.4 $0.43 1/15/2024675,700 shares $333,322.81 +0.4%N/A0.5 $0.49 Get the Latest News and Ratings for ALLR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allarity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023673,000 shares $370,890.30 -72.9%N/A0.5 $0.55 12/15/20232,480,000 shares $1.31 million +1,672.7%N/A1.7 $0.53 11/30/2023139,900 shares $77,392.68 -26.3%N/A0.1 $0.55 11/15/2023189,800 shares $93,951.00 -19.2%N/A0.6 $0.50 10/31/2023234,800 shares $130,783.60 -18.5%N/A0.8 $0.56 10/15/2023288,200 shares $208,483.88 +8.9%N/A0.5 $0.72 9/30/2023264,600 shares $197,656.20 -2.9%N/A0.4 $0.75 9/15/2023272,600 shares $258,970.00 +994.8%N/A0.3 $0.95 8/31/202324,900 shares $46,065.00 -15.6%N/A0 $1.85 8/15/202329,500 shares $57,230.00 +118.5%N/A0 $1.94 7/31/202313,500 shares $34,290.00 -78.6%N/A0 $2.54 7/15/202363,000 shares $190,260.00 +176.3%N/A0.2 $3.02 6/30/202322,800 shares $150,480.00 -87.8%N/A0.1 $6.60 6/15/2023186,300 shares $35,601.93 -33.6%N/A0.1 $0.19 5/31/2023280,600 shares $73,938.10 -40.4%N/A0.1 $0.26 5/15/2023470,800 shares $180,316.40 +180.4%N/A0.2 $0.38 4/30/2023167,900 shares $73,876.00 +21.1%N/A0.1 $0.44 4/15/2023138,700 shares $199,728.00 +134.7%N/A0.1 $1.44 3/31/202359,100 shares $99,288.00 -70.0%N/A0.3 $1.68 3/15/2023196,700 shares $894,985.00 -71.6%1.5%0 $4.55 2/28/2023691,700 shares $127,964.50 +23.8%7.5%0.3 $0.19 2/15/2023558,800 shares $105,054.40 -38.7%6.1%0.2 $0.19 1/31/2023911,800 shares $227,950.00 +320.4%9.9%0.4 $0.25 1/15/2023216,900 shares $52,923.60 +38.9%2.4%0.1 $0.24 12/30/2022156,200 shares $45,891.56 +39.2%1.7%0.2 $0.29 12/15/2022112,200 shares $29,733.00 +2,852.6%1.3%0.2 $0.27 11/30/20223,800 shares $1,706.20 -56.3%0.1%0 $0.45 11/15/20228,700 shares $4,352.61 -46.0%0.1%0.1 $0.50 10/31/202216,100 shares $9,017.61 -13.9%0.2%0.1 $0.56 10/15/202218,700 shares $15,427.50 +167.1%0.3%0.1 $0.83 9/30/20227,000 shares $7,700.00 -94.0%0.1%0 $1.10 9/15/2022117,400 shares $147,924.00 +161.5%1.6%0.4 $1.26 8/31/202244,900 shares $52,533.00 +77.5%0.6%0.2 $1.17 8/15/202225,300 shares $28,083.00 -57.4%0.3%0.1 $1.11Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story ALLR Short Interest - Frequently Asked Questions What is Allarity Therapeutics' current short interest? Short interest is the volume of Allarity Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 25,200 shares of ALLR short. 9.18% of Allarity Therapeutics' shares are currently sold short. Learn More on Allarity Therapeutics' current short interest. What is a good short interest ratio for Allarity Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALLR shares currently have a short interest ratio of 1.0. Learn More on Allarity Therapeutics's short interest ratio. What is a good short interest percentage for Allarity Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.18% of Allarity Therapeutics' floating shares are currently sold short. Is Allarity Therapeutics' short interest increasing or decreasing? Allarity Therapeutics saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 25,200 shares, a drop of 95.9% from the previous total of 614,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Allarity Therapeutics' float size? Allarity Therapeutics currently has issued a total of 310,000 shares. Some of Allarity Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Allarity Therapeutics currently has a public float of 274,600 shares. How does Allarity Therapeutics' short interest compare to its competitors? 9.18% of Allarity Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Allarity Therapeutics: Aditxt, Inc. (0.99%), Aptevo Therapeutics Inc. (5.13%), China SXT Pharmaceuticals, Inc. (4.78%), Evelo Biosciences, Inc. (2.11%), Neptune Wellness Solutions Inc (0.54%), SciSparc Ltd. (24.15%), Biodexa Pharmaceuticals Plc (5.18%), Baudax Bio, Inc. (1.11%), 180 Life Sciences Corp. (8.36%), PainReform Ltd. (1.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Allarity Therapeutics stock? Short selling ALLR is an investing strategy that aims to generate trading profit from Allarity Therapeutics as its price is falling. ALLR shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Allarity Therapeutics? A short squeeze for Allarity Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALLR, which in turn drives the price of the stock up even further. How often is Allarity Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALLR, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Aditxt Short Interest Aptevo Therapeutics Short Interest China SXT Pharmaceuticals Short Interest Evelo Biosciences Short Interest Neptune Wellness Solutions Short Interest SciSparc Short Interest Biodexa Pharmaceuticals Short Interest Baudax Bio Short Interest 180 Life Sciences Short Interest PainReform Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALLR) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe “Perfect Storm” for GoldGold Safe ExchangeBiden replacement revealed?Paradigm PressThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving Trends